Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
140 USD | +0.69% | +0.21% | +6.35% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.35% | 13.99B | |
+2.70% | 108B | |
+10.19% | 105B | |
+1.57% | 23.46B | |
-12.33% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-7.11% | 17.19B | |
+35.87% | 12.53B | |
+332.25% | 8.81B |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- Wells Fargo Upgrades Neurocrine Biosciences to Overweight From Equalweight, Price Target is $170